Search Results
Found 1 results
510(k) Data Aggregation
(124 days)
VANGUARD REPROCESSED NON-ELECTRIC BIOPSY FORCEPS
GI forceps are designed for insertion through an appropriate sized endoscopy channel for removal and histological sampling of tissue. Biopsy forceps are intended for removal of polyps and/or tissue within the gastrointestinal tract.
Vanguard Reprocessed Non-Electric Biopsy Forceps consist of a flexible sheath with distal grasping cups controlled by a proximal control handle. When used with a compatible endoscope, GI biopsy forceps are intended for removal of polyps and/or tissue within the gastrointestinal tract. Biopsy forceps are designed for insertion through a predetermined diameter biopsy channel. Vanguard receives previously used non-electric GI biopsy forceps from healthcare facilities; cleans, inspects, tests, packages, labels, and sterilizes the devices; and returns them to a healthcare facility for subsequent use.
The provided text describes the 510(k) summary for the Vanguard Reprocessed Non-Electric Biopsy Forceps and does not contain the specific information requested about acceptance criteria, device performance tables, study designs (sample sizes, provenance, ground truth, experts, adjudication, MRMC, standalone), or training set details.
The document focuses on:
- Device Description: Reprocessed non-electric GI biopsy forceps.
- Intended Use: Removal and histological sampling of tissue/polyps within the GI tract.
- Technological Characteristics: "Essentially identical" to OEM devices with no changes to materials or specifications.
- Predicate Devices: Various OEM non-electric biopsy forceps (Class I, 510(k) exempt).
- Test Data: States that "Cleaning, sterilization, packaging validations, and performance and biocompatibility testing demonstrate that the reprocessed devices perform as intended and are safe and effective."
Therefore, I cannot fulfill your request for the detailed acceptance criteria and study information as it is not present in the provided text.
The document only broadly states that "performance and biocompatibility testing demonstrate that the reprocessed devices perform as intended and are safe and effective," but does not give any specifics on:
- Quantitative acceptance criteria (e.g., minimum tensile strength, maximum residual protein).
- Reported device performance against those criteria.
- Sample sizes for test sets.
- Data provenance.
- Number/qualifications of experts.
- Adjudication methods.
- MRMC or standalone studies.
- Types of ground truth.
- Training set details.
Ask a specific question about this device
Page 1 of 1